Neuropsych treatment & diagnosis platform dev Mindstrong Health raises $14m in Series A

June 16, 2017 By Fink Densford Leave a Comment

Neurological-focused device start-up Mindstrong Health said yesterday it raised $14 million in a Series A round of financing to support its neuropsychiatric treatment and diagnosis platform.

Mindstrong’s AI-powered platform is designed to monitor patterns of interaction on smartphone devices to objective measures of brain function.

The company’s platform aims to provide “continuous digital biomarkers of mood and cognition,” which it said includes processing speed, attention, memory and executive function.

“What excites me about Mindstrong is the transformation of an individual’s patterns of typing or scrolling on a smartphone into precise measures of cognitive function. This new, powerful approach to assessment serves as the foundation for developing better interventions to improve mental health care. Mental disorders are global health problems. With smartphones we have a potential global solution,” Mindstrong Health co-founder & prez Dr. Tom Insel said in prepared remarks.

The round was led by Foresite Capital and ARCH Venture Partners, and was joined by Optum Ventures, Berggruen Holdings and the One Mind Brain Health Impact fund, according to the Palo Alto, Calif.-based company.

“Mindstrong Health’s founding team brings unmatched understanding of the critical challenges surrounding the way in which the medical community cares for patients suffering from cognitive health disorders. By fusing together Paul, Rick, and Tom’s collective experience, leadership, and technical vision, those concerned with improving patient outcomes will gain an innovative platform that modernizes and vastly improves the way in which care is provided,” Foresite Capital CEO Jim Tananbaum said in a prepared statement.

The company said that results from its clinical trial will be released in the coming months to support the platform.

“All modern medicine is based on objective measurement, yet tracking mental health has been limited to subjective reports in a clinical environment. To improve outcomes for people with mental disorders, we need the kind of objective measures we have for other chronic diseases like diabetes and heart disease. Mindstrong’s technology delivers continuous, objective measures of behavior and cognition at a level of resolution and insight that has never been possible,” Mindstrong Health CEO Dr. Paul Dagum said in a press release.

Accu-Tube launches rebrand for 45 year anniversary
Accu-Tube announced that it has updated its branding with a new logo, colors and website during the company’s 45 year anniversary celebration. The new branding comes with improvements to the company that will go toward helping Accu-Tube grow and expand. “We are very proud of our reconfiguration across all spaces,” Kevin McGrath, CEO of Accu-Tube,… […]
Spectrum Plastics adds overmolding at Utah plant
Spectrum Plastics Group said today that it has begun to offer value-added overmolding at its Apollo Medical operation in Sandy, Utah. The Alpharetta, Ga.-based company added four new injection molding machines ranging from 11 to 55 tons, at Apollo. The machines are suitable for injection molding of highly precise products, including dilator and sheath sets, allowing Spectrum to… […]
11 innovative medical devices you need to know from 2018
Call it digital health or mHealth or simply what it is — innovation. Last year we saw a lot of innovative wireless devices for diagnostics and treatment as research and development flourished. Many researchers have taken up the challenge of developing devices that are portable, small and convenient with ease-of-use that could revolutionize point-of-care diagnostics… […]
Study of VentureMed’s Flex catheter begins in Switzerland
Vascular-focused device developer VentureMed said yesterday that it has launched another study of its Flex dynamic scoring catheter, this one to measure how open patients’ blood vessels remain 12 months after treatment. The prospective, single arm, non-randomized study in Switzerland will enroll up to 150 patients whose superficial femoral and popliteal arteries were scored by the Flex system… […]
Grand Valley State lands grant to study 3D printing for medtech
Grand Valley State University’s applied Medical Device Institute (aMDI) has been awarded $500,000 by the Grand Rapids SmartZone to study the use of specialized 3D printing technology for medical device production. The grant will allow the Grand Rapids, Michigan-based institute, along with contract manufacturer MediSurge (Grand Rapids) and 3D printing company Carbon (Redwood City, Calif.) to create production-grade,… […]
Abbott inks deal to test blood donations in Japan
Abbott (NYSE:ABT) said today that it has been selected by the Japanese Red Cross Society (JRC) to partner in screening the country’s blood donations. The eight-year contract is for the exclusive supply of serological instrumentation, tests, and consumables used for blood and plasma screening. The JRC screens approximately 5 million blood donations each year, helping ensure… […]
LivaNova touts studies of its sutureless aortic valve
LivaNova (NSDQ:LIVN) said today that three separate, recently published studies highlight the performance and cost savings of its sutureless aortic valve, Perceval. The results from the Perceval Aortic Heart Valve Study in North America found that Perceval achieves positive safety and efficacy outcomes whether or not an open or minimally invasive surgical approach is used. The… […]
OtoNexus raises $4.4 million for ear infection detection technology
OtoNexus (Seattle) has raised more than $4.4 million as it continues to develop its ultrasound medical device technology to diagnose middle ear infections, according to a U.S. Securities and Exchange Commission Form D filed this month. OtoNexus has been seeking a nearly $8.3 million from the money-raise. It previously raised $7.8 million in 2017. Funders and supporters… […]
Bioventus launches Osteomatrix+ bone graft
Bioventus announced today that it has started selling Osteomatrix+ – a moldable bone graft substitute intended for a variety of orthopedic and spine bone remodeling applications. Bioventus officials boast that Osteomatrix+ has improved moldability, flexibility and versatility versus its predecessor. “Osteomatrix+ represents the first of several next-generation products that will be added to the Bioventus portfolio… […]
European scientists develop absorbable bandages for burn patients
An international research group has developed a biocompatible bandage material that has antibacterial properties and will not require changing, a potential boon for burn patients. The material is self-absorbable, and a new bandage can be put directly on top of the old one, alleviating the need for the frequent and often-painful changing of a burn… […]
17 MD&M West exhibitors you need to know
More than 20,000 engineers and executives are expected to gather and network for the annual MD&M West – one of the largest annual medical device manufacturing events. MD&M West takes place at the Anaheim Convention Center in Anaheim, Calif., Feb. 5–7, and houses an array of industry suppliers showcasing their latest technologies and manufacturing advancements. Think medical device packaging,… […]